One patient was excluded due to concurrent leptomeningeal metastases; two patients were excluded due to simultaneous diagnosis with other cancers; six patients had combined histology; and four patients received NK-cell immunotherapy before or after PD-1/PD-L1 treatment. This evidence concerns the gene PDCD1 and cancer.